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ABSTRACT 1 
 Chronic inflammation that occurs with aging is one of the risk factors for 2 
cardiovascular disease. Regular exercise may prevent cardiovascular morbidity by 3 
decreasing chronic systematic inflammation. Additionally, excess inflammation can be 4 
reduced by the anti-inflammatory protein pentraxin 3 (PTX3). Thus, both habitual 5 
exercise and PTX3 have an anti-inflammatory effect. However, it is unclear whether 6 
regular exercise leads to increased plasma PTX3 concentration. In the present study, 7 
we investigated the effects of regular aerobic exercise on plasma PTX3 concentration 8 
in middle-aged and elderly women. Twenty-two postmenopausal women (60 ± 6 yrs) 9 
were randomly divided evenly into 2 groups (i.e., exercise intervention and control). 10 
Subjects in the exercise group completed 2 months of regular aerobic exercise 11 
training (walking and cycling, 30-45min, 3-5 days/wk). Before and after the 12 
intervention, we evaluated plasma PTX3 concentration, peak oxygen uptake 13 
(VO2peak), blood chemistry, and arterial distensibility (carotid arterial compliance and 14 
β-stiffness) in all participants. There were no significant differences in baseline 15 
parameters between the 2 groups. Plasma PTX3 concentration was significantly 16 
increased in the exercise group after the intervention (P < 0.05). HDL cholesterol, 17 
VO2peak, and arterial compliance were also significantly increased (P < 0.05), while 18 
β-stiffness was markedly decreased (P < 0.01) after the intervention. On the other 19 
hand, there was no change in the parameters tested in the control group. This study 20 
demonstrates that regular aerobic exercise increases plasma PTX3 concentration 21 
with improvement of HDL cholesterol, VO2peak, and arterial distensibility in 22 
postmenopausal women. 23 
 24 
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INTRODUCTION 1 
 Cardiovascular disease is the leading cause of death worldwide. Systemic 2 
inflammatory factors increase with age, which lead to an increased risk of 3 
cardiovascular disease in middle-aged and elderly individuals (Kritchevsky et al. 4 
2005). Inflammatory factors can be classified as pro-inflammatory or 5 
anti-inflammatory, depending on their function. Several pro-inflammatory cytokines 6 
increase gradually with aging, causing an imbalance in the levels of pro- and 7 
anti-inflammatory factors. This is of particular concern for middle-aged and elderly 8 
women, whose risk of cardiovascular disease increases during menopause due to 9 
declining estrogen levels, in addition to the increase in systemic inflammation due to 10 
aging (Reckelhoff. 2006). Therefore, it is important for postmenopausal middle-aged 11 
and elderly women to modulate the balance of systemic inflammatory factors to 12 
reduce the risk of cardiovascular disease. 13 
 Physical inactivity, as well as aging, may induce systemic inflammation. It has 14 
been suggested that regular physical activity may contribute to lower levels of 15 
pro-inflammatory and higher levels of anti-inflammatory factors (Mathur and 16 
Pedersen. 2008). Furthermore, exercise can decrease several kinds of 17 
pro-inflammatory factors in elderly individuals (Roubenoff. 2007). Thus, regular 18 
exercise may decrease excess inflammation due to aging and/or physical inactivity, 19 
reducing the risk of cardiovascular disease in elderly individuals. 20 
Pentraxin 3 (PTX3) may be a biomarker of cardiovascular events, in that it 21 
increases with the progression of atherosclerosis (Rolph et al. 2002). Recently, PTX3 22 
has been established as an anti-inflammatory protein in atherosclerosis (Norata et al. 23 
2010). In previous studies using PTX3-deficient or PTX3-over expressing mice, it has 24 
been shown that PTX3 has an anti-inflammatory and/or anti-atherosclerotic role (Dias 25 
et al. 2001;Norata et al. 2008). It has been reported that a bout of endurance exercise 26 
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or resistance exercise increases plasma PTX3 concentrations in young healthy men 1 
(Nakajima et al. 2010). We demonstrated that plasma PTX3 concentrations in young 2 
endurance-trained men were higher than age-matched sedentary controls (Miyaki et 3 
al. 2011). On the other hand, it has been reported that plasma PTX3 concentrations 4 
decreased with exercise training in patients undergoing cardiac rehabilitation (Fukuda 5 
et al. 2011). However, it is unclear whether aerobic exercise training affects circulating 6 
PTX3 concentration in healthy middle-aged and elderly individuals. The purpose of 7 
the present study was to investigate the effect of an 8-week aerobic exercise 8 
intervention on plasma PTX3 concentration in healthy postmenopausal middle-aged 9 
and elderly women. 10 
 11 
METHODS 12 
 Subjects. Twenty-two sedentary or recreationally active (e.g., stretching 13 
exercise, yoga or golf) postmenopausal women participated in the study (age: 52–77 14 
years). Prior to enrollment onto the study, participants answered a questionnaire 15 
about their lifestyle and postmenopausal condition. Individuals taking 16 
anti-inflammatory, anti-hypertensive, or steroidal drugs and hormone replacement 17 
were excluded. Subjects were nonsmokers, nonobese, and free of overt 18 
cardiovascular disease, as assessed by medical history and physical examination 19 
and all were at least 2 years post menopause. Subjects were randomly assigned to 20 
the exercise or control group before all measurements. The control group requested 21 
to maintain normal habits. This study was reviewed and approved by the Institutional 22 
Review Board at the University of Tsukuba. All potential risks and procedures of the 23 
study were explained to the subjects, who provided a written informed consent to 24 
participate in the study. Before and after the intervention, all measurements 25 
(excluding peak oxygen consumption) were performed between 8 a.m. and 12 p.m. 26 
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after an overnight fast. Subjects were studied under supine resting conditions in a 1 
quiet, temperature-controlled room (24–26°C). All measurements were performed 2 
after a resting period of at least 20 min.  3 
 4 
 Exercise Intervention. Subjects in the exercise group underwent aerobic 5 
exercise training 3–5 days/wk (more than 3 supervised sessions, and additional 6 
home-based training) for 8 weeks. Initially, subjects performed walking or cycling 7 
30–40 min/day, at a relatively low intensity (at least 60% of their individually 8 
determined maximal heart rate). As their exercise tolerance improved, the intensity 9 
and duration of aerobic exercise were increased to 40–45 min/day, at an intensity of 10 
70–75% of maximal heart rate. We instructed walking for 30-45 min/day at an 11 
intensity of 60-75% of maximal heart rate as additional home-based training. There 12 
were no adverse events with the exercise intervention. 13 
 14 
 Peak Oxygen Consumption. To determine peak oxygen consumption 15 
(VO2peak) all subjects underwent an incremental cycle exercise test (2 min at 40 W 16 
with 20 W increases every 2 min) on a cycle ergometer (75XL, COMBI wellness, 17 
Tokyo). Throughout this test, heart rate, ratings of perceived exertion (Borg scale) 18 
and breath by breath oxygen consumption and carbon dioxide production were 19 
monitored (AE300S; Minato Medical Science, Osaka, Japan). The values of peak 20 
oxygen uptake were accepted if subjects met at least two of the following criteria: a 21 
VO2 plateau (<150 mL O2 per minute with an increased work rate), highest respiratory 22 
exchange ratio > 1.15, peak heart rate within 5 beats of the age-predicted maximum 23 
(220 - age), rating of perceived exertion > 19, or extreme fatigue such that the 24 
pedaling rate on the bicycle ergometer was < 50 rpm.  25 
 26 
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 Plasma Pentraxin 3 Concentration. Plasma pentraxin 3 (PTX3) was 1 
measured as previously described (Miyaki et al. 2011). Briefly, each blood sample 2 
was placed in a chilled tube containing ethylenediaminetetraacetic acid (2 mg/mL) 3 
and centrifuged at 2000 g for 15 min at 4°C. The plasma was stored at -80°C until 4 
analysis. Plasma concentrations of PTX3 were determined using a commercial 5 
enzyme-linked immunosorbent assay (ELISA) kit (Quantikine DPTX 30; R&D 6 
Systems Inc., Minneapolis, USA). The PTX3 assay was carried out according to the 7 
manufacturer’s instructions. The intra-assay coefficients of variation in plasma PTX3 8 
levels were 2.2 % in this study.  9 
 10 
Blood Biochemistry. Serum concentrations of total cholesterol (TC), high-density 11 
lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), 12 
triglycerides (TG), and fasting plasma concentrations of glucose (FBG) were 13 
determined using standard enzymatic techniques. TC and TG concentrations were 14 
determined by the cholesterol dehydrogenase and glycerol kinase methods, 15 
respectively (Allain et al. 1974; Kohlmeler et al. 1984). LDL-C and HDL-C 16 
concentrations were measured by a direct method (Finley et al. 1978; Yamashita et al. 17 
2008). The FBG concentration was assayed by the hexokinase and 18 
glucose-6-phosphate dehydrogenase methods (Slein et al. 1963). 19 
 20 
 Blood Pressure. The supine systolic blood pressure, diastolic blood 21 
pressure, mean arterial pressure, and heart rate (HR) were recorded from the left arm 22 
using a semi-automated device (form PWV/ABI; Colin Medical Technology, Komaki, 23 
Japan). 24 
 25 
Carotid Artery Distensibility. Dynamic arterial compliance was 26 
Miyaki et al.-R2   Page 6 
 
 
noninvasively determined using a combination of ultrasonography of the common 1 
carotid artery and simultaneous applanation tonometry of the contralateral carotid 2 
artery, as previously described (Miyaki et al. 2009). Briefly, subjects were examined in 3 
the supine position under quiet resting conditions. The diameter of the common 4 
carotid artery was measured using images from an ultrasound machine (EnVisor; 5 
Koninklijke Philips Electronics, Eindhoven, the Netherlands) equipped with a 6 
high-resolution (7.5 MHz) linear array transducer. Pressure wave forms of the left 7 
common carotid artery were recorded with an applanation tonometry device (form 8 
PWV/ABI) and calibrated by equating the mean arterial and diastolic blood pressure 9 
values of the carotid artery to those of the brachial artery. 10 
The β-stiffness index provides an index of arterial compliance adjusted for 11 
distending pressure, as previously described (Miyaki et al. 2009). Briefly, the 12 
β-stiffness index was calculated using the equation β = ln (Ps/Pd)/([Ds – Dd]/Dd), 13 
where Ds and Dd are the maximum and minimum inner arterial diameters, and Ps 14 
and Pd are the highest and lowest blood pressures, respectively. All image analyses 15 
were performed by the same investigator. 16 
  17 
 Statistical Analysis. Data are expressed as means ± SD. Statistical analysis 18 
was performed by a 2-way (time-by-group) ANOVA with repeated measures to 19 
determine the effects of the 2 different interventions. For intergroup comparisons, an 20 
unpaired student's t test was used. P < 0.05 was accepted as significant. 21 
 22 
RESULTS 23 
 All 11 participants in the exercise group completed the 8-week aerobic 24 
exercise training (at least 3 days per week). Table 1 summarizes the characteristics of 25 
the subject groups before and after the intervention. There were no significant 26 
Miyaki et al.-R2   Page 7 
 
 
differences at baseline in age, height, weight, BMI, TG, TC, LDL-C, FBG and 1 
VO2peak between the 2 groups. HDL-C and VO2peak were significantly increased in 2 
the exercise group after the 8-week aerobic exercise program. On the other hand, 3 
there were no significant differences in the parameters tested before and after the 4 
intervention in the control group (Table 1). Before the intervention, there was no 5 
difference in the baseline plasma PTX3 concentration between the groups. After the 6 
intervention, plasma PTX3 concentration in the exercise group significantly increased 7 
(Figure 1). There was no significant change in plasma PTX3 concentration in the 8 
control group. Table 2 shows the hemodynamic changes before and after the 9 
intervention. In the exercise group, there were no significant differences in blood 10 
pressure and HR before and after the intervention. On the other hand, arterial 11 
compliance significantly increased and β-stiffness significantly decreased in the 12 
exercise group after the aerobic exercise intervention. The control group showed no 13 
significant changes in hemodynamic parameters before and after the intervention 14 
(Table 2). In all participants, the percent changes in plasma PTX3 concentration and 15 
those in arterial compliance be positively correlated (R = 0.40, P = 0.07). 16 
 17 
DISCUSSION 18 
 It is recognized that an imbalance of inflammatory factors (i.e., increasing 19 
pro-inflammatory and decreasing anti-inflammatory substances) due to physical 20 
inactivity is a risk factor for cardiovascular disease in middle-aged and elderly 21 
individuals (Mathur and Pedersen. 2008). Habitual aerobic exercise is thought to 22 
have an anti-inflammatory effect. Regular exercise promotes an increase in 23 
anti-inflammatory factors (interleukin-1 and interleukin-10) in the circulation (Petersen 24 
and Pedersen. 2005). Furthermore, long-term aerobic exercise can decrease 25 
systemic pro-inflammatory factors (C-reactive protein and tumor necrosis 26 
. . 
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factor-alpha) in middle-aged and elderly individuals (Mathur and Pedersen. 2008). 1 
We previously reported that plasma PTX3 concentrations in young endurance-trained 2 
men were significantly higher than age-matched sedentary controls (Miyaki et al. 3 
2011). However, the effect of habitual aerobic exercise on systemic PTX3 levels in 4 
middle-aged and elderly individuals remained unclear. In the present study, we 5 
demonstrated that plasma PTX3 concentration in healthy sedentary or recreationally 6 
active postmenopausal middle-aged and elderly women was significantly increased 7 
after an 8-week moderate aerobic exercise intervention. Thus, habitual aerobic 8 
exercise increased plasma PTX3 concentration possibly as an anti-inflammatory 9 
effect in healthy postmenopausal middle-aged and elderly women. 10 
 Elevated systemic inflammation is known to be one of the mechanisms that 11 
promotes cardiovascular diseases (Ross. 1993). Circulating levels of inflammatory 12 
factors are a useful clinical diagnostic tool to measure the state of cardiovascular 13 
disease (Petersen and Pedersen. 2005; Wilund. 2007). PTX3 may be a biomarker of 14 
cardiovascular events, in that it increases with the progression of atherosclerosis 15 
(Rolph et al. 2002). Importantly, PTX3 is mainly produced from cells composing the 16 
arterial wall (i.e., endothelial cells, smooth muscle cells, and macrophages) at the 17 
local part of atherosclerotic lesion (Savchenko et al. 2008). It has been suggested 18 
that PTX3 modulates the balance of pro- and anti-inflammatory factors (Norata et al. 19 
2009). Compared to wild-type mice, PTX3-overexpressing mice are protected against 20 
a lethal dose of lipopolysaccharide (Dias et al. 2001). This may indicate that PTX3 21 
controls excess pro-inflammatory reaction and defend the body against the lethal 22 
damage. Furthermore, PTX3-deficient mice fed a western-diet have a greater area of 23 
inflammatory atherosclerosis in the aorta than controls (Norata et al. 2008). It has 24 
been demonstrated that ischemic-reperfusion treatment in PTX3-deficient mice at the 25 
aortic arch significantly increases apoptosis in cardiovascular tissue. Such an 26 
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increase in apoptotic cells can be abrogated by administration of exogenous PTX3 1 
(Salio et al. 2008). Recently, it has been postulated that elevation of PTX3 during 2 
cardiovascular disease may be a compensatory response by the body and serve to 3 
protect it from inflammation (Norata et al. 2010). Thus, these results suggest that 4 
PTX3 is an anti-inflammatory protein and has an important protective role in 5 
cardiovascular inflammation. In the present study, 8-week aerobic exercise training 6 
caused not only an increase in plasma PTX3 concentration, but also increased 7 
arterial distensibility and HDL-C in postmenopausal women. Decreases in arterial 8 
distensibility and HDL-C are characteristic of aging, and are known risk factors for 9 
cardiovascular disease morbidity (Chan et al. 1999; Safar and London. 2000). The 10 
percent change in plasma PTX3 concentration and that in arterial compliance tended 11 
to have positive correlation (R = 0.40, P = 0.07). Taken together, our results suggest 12 
that an increase in PTX3 by moderate aerobic exercise training may contribute to the 13 
cardiovascular protective effect in healthy postmenopausal middle-aged and elderly 14 
women. 15 
 The present study has the following study limitations. We demonstrated that 16 
plasma PTX3 concentrations increased after aerobic exercise training. However, the 17 
increase in plasma PTX3 concentration was very small. At this stage, it is unclear 18 
whether such a small increase in PTX3 has a clinical significance. Furthermore, there 19 
is one recent study on exercise training in patients undergoing cardiac rehabilitation 20 
that found that plasma PTX3 concentrations decreased with exercise training 21 
(Fukuda et al. 2011). In the present study, exercise training increased plasma PTX3 22 
concentration in healthy middle-aged and elderly subjects. The difference in subjects 23 
(i.e., patients with cardiovascular disease or healthy individuals) may affect the 24 
response of plasma PTX3 concentrations during exercise training. However, we can 25 
not explain the reason for the contradictory results between these studies at present. 26 
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Moreover, it is unclear the mechanism/s behind increases in plasma PTX3 1 
concentration after aerobic exercise training in postmenopausal middle-aged and 2 
elderly women. Further study is needed to reveal the mechanism underlying increase 3 
in plasma PTX3 concentration after aerobic exercise training. 4 
 In conclusion, 8 weeks of moderate aerobic exercise training increased 5 
plasma PTX3 concentration in healthy postmenopausal middle-aged and elderly 6 
women, and this may partly participate in the mechanism underlying aerobic exercise 7 
training-induced anti-inflammatory effect and cardiovascular protection. 8 
9 
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FIGURE LEGENDS 1 
Figure 1. Plasma PTX3 concentration before and after the 8-week intervention. Data 2 
are expressed as mean ± SD. 3 
 4 
Table 1 Selected subject characteristics before and after the intervention 
 
Data are expressed as means ± SD. TC , total cholesterol; TG, triglyceride; HDL-C, hdl cholesterol; LDL-C; ldl cholesterol; 
FBG, fasting blood glucose; VO2peak, peak oxygen consumption. *P < 0.05 vs. before the intervention. 
 
 
 
 
  Exercise Control 
  Pre Post Pre Post 
Age, yrs 60 ± 6 - 60 ± 7 - 
Height, m 1.53 ± 4.2 - 1.54 ± 6.2 - 
Weight, kg 52.0  ± 5.5  52.0  ± 5.7  53.1  ± 7.1  53.4  ± 6.8  
BMI, kg/m2 22.2  ± 2.0  22.2  ± 2.1  22.4  ± 2.6  22.5  ± 2.4  
TC, mmol/l 5.79  ± 0.83  5.97  ± 0.7  5.72  ± 0.52  5.87  ± 0.62  
TG, mmol/l 1.17  ± 0.45  1.06  ± 0.48  1.24  ± 0.59  1.37  ± 0.58  
HDL-C, mmol/l 1.68  ± 0.28  1.86  ± 0.31* 1.68  ± 0.39  1.68  ± 0.34  
LDL-C, mmol/l 3.57  ± 0.72  3.67  ± 0.62  3.47  ± 0.39  3.49  ± 0.44  
FBG, mmol/l 5.00  ± 0.44  5.17  ± 0.33  4.89  ± 0.44 4.94  ± 0.39  
VO2peak , ml/min/kg 24.7  ± 4.6  26.8  ± 5.4* 23.1  ± 4.8  22.1  ± 3.6  
             
. 
. 
Table. 2 Hemodynamic changes before and after the intervention 
 
 
Data are expressed as means ± SD. SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; CAC, 
carotid arterial compliance. *P < 0.05, **P < 0.01 vs. before the intervention. 
 
  Exercise Control 
  Pre Post Pre Post 
SBP, mmHg 97  ± 12  100  ± 15  107  ± 14  110  ± 13  
DBP, mmHg 63  ± 6  62  ± 7  68  ± 9  69  ± 6  
HR, bpm 58  ± 5  56  ± 4  64  ± 8  63  ± 8  
CAC, mm2/mmHg 0.083  ± 0.019  0.092  ± 0.023* 0.091  ± 0.019  0.090  ± 0.020  
β-stiffness 8.72 ± 2.05 7.76 ± 1.97** 7.58  ± 1.34  7.71  ± 1.51  
Exercise Control 
0.85 
0.75 
0.55 
0.45 
P < 0.05 
Pre Post Pre Post 
ng/ml 
0.65 
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Figure 1 (Miyaki et al.)  
